Kinova®, a privately-held developer of robotic solutions, announced today the signing of a five-year agreement for robots manufacturing and development with Auris Health, Inc., a subsidiary of Ethicon, Inc., part of the Johnson & Johnson Medical Devices Companies since 2019, with the option to extend for a further three years. As part of the agreement, Kinova will continue to support Auris in the expansion of the MONARCH® Platform, leveraging the firm’s capacity and expertise to deliver integrated and cost-effective robotic solutions.
Since 2015, Kinova has had a strategic agreement with Auris for the MONARCH® Platform, a first-of-its-kind robotic technology indicated for use in diagnostic and therapeutic bronchoscopic procedures. Through this agreement, Kinova worked with the team at Auris to define and develop a purpose-built robotic arm to help enable meaningful progress in surgery.
“An important part of Kinova’s vision is to use medical robotics for optimal patient outcomes and enable humans in the process with better tools. We have worked with the Auris team to advance the development of disruptive robotic solutions for the last 6 years, and we are excited to continue our strategic agreement to help advance the frontier of surgery.” said Charles Deguire, CEO & Co-Founder of Kinova. “The MONARCH® Platform demonstrates perfectly Kinova’s capacity to support the robotization, through strategic partnerships and collaborative efforts, of global leaders in the medical device space. Robotics has evolved, there’s this new generation of connected and integrated robots, and we are committed to enabling companies to take full advantage of it.”
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!
